From Texas Health and Human Services Commission <[email protected]>
Subject Semi-annual Medicaid Preferred Drug List Update Coming Jan. 26th
Date December 12, 2022 6:01 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Texas Health and Human Services [ [link removed] ]

Blue Gradient


Semi-annual Medicaid Preferred Drug List Update Coming Jan. 26th

HHSC will publish the semi-annual update of the Medicaid preferred drug list [ [link removed] ] on Jan. 26, 2023. HHSC made the PDL changes based on recommendations made at the July and October 2022 Texas Drug Utilization Review Board meetings.

Other news

* Genabio COVID-19 At-Home Test Kit Added to Formulary [ [link removed] ]
* Clinical Prior Authorization for Calcitonin Gene-Related Peptide Receptor Antagonists in Traditional Medicaid Begins Dec. 30 [ [link removed] ]
* Hepatitis C Treatment Coverage and PDL Update Scheduled for Jan. 1 [ [link removed] ]

 









________________________________________________________________________

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website [ [link removed] ].

________________________________________________________________________

Stay Connected Visit us on Facebook [ [link removed] ] Visit us on YouTube [ [link removed] ] Visit us on Twitter [ [link removed] ] Visit us on Instagram [ [link removed] ] Visit us on Facebook [ [link removed] ]  (en español)  

Bookmark and Share [ [link removed] ]

Subscriber Services
Manage Preferences [ [link removed] ]  |  Unsubscribe [ [link removed] ]  |  Help [ [link removed] ]

________________________________________________________________________

This email was sent to [email protected] using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202 GovDelivery logo [ [link removed] ]
Screenshot of the email generated on import

Message Analysis